Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Development of a Clinical Risk Score for Early Left Ventricular Thrombus Prediction Following Anterior ST-Segment Elevation Myocardial Infarction
Session:
Sessão de Posters 36 - Antiagregação plaquetar
Speaker:
Vanda Neto
Congress:
CPC 2024
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
13. Acute Coronary Syndromes
Subtheme:
13.4 Acute Coronary Syndromes – Treatment
Session Type:
Cartazes
FP Number:
---
Authors:
Vanda Devesa Neto; Mariana Almeida; João Fiúza; Gonçalo Ferreira; Nuno Craveiro; Inês Pires; Joana Correia; António Costa
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:#0e101a">Introduction:</span></strong><span style="color:#0e101a"> Despite improvements in the management of ST-segment elevation myocardial infarction (STEMI), the risk of left ventricular thrombus (LVT) remains a significant concern due to its potential for embolic complications. Early identification of patients at high risk for LVT is crucial for guiding therapeutic interventions and improving clinical outcomes. </span><span style="color:#0e101a">This study aimed to develop a practical and clinically applicable risk score that integrates readily available demographic, clinical, and echocardiographic parameters to predict the likelihood of early LVT formation post anterior STEMI.</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:#0e101a">Methods:</span></strong><span style="color:#0e101a"> A single-center study was performed including all patients admitted due to anterior STEMI and performed echocardiography in the days following the event. The newly designed score was calculated for each patient (0-15 points), after identification of the variables significantly associated with LVT formation (points attributed for each variable according to odds ratio). The score incorporates age, clinical presentation (Killip-Kimball classification), history of previous myocardial infarction and atrial fibrillation, and echocardiographic findings (left ventricular ejection fraction and apical aneurysm). ROC curve analysis was performed to evaluate the predictive value of the score. </span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:#0e101a">Results:</span></strong><span style="color:#0e101a"> 68 patients; mean age was 66.1±13.5; 81% male. History of previous myocardial infarction in 16% and 6% had atrial fibrillation. Killip-Kimball (KK) classification at admission was 57% in class I, 32% in class II, 2% in class III, and 9% in class IV. Fibrinolysis was performed in 27% of patients. Mean door-to-balloon time was 138.9±123.4 minutes. 13% presented >12h after symptom onset. Successful reperfusion (Grade 3 in TIMI classification) in 84% of patients. Median LVEF was 41.2±8.6%; apical aneurism in 34%. Contrast echocardiography was performed in 56% of patients. Apical thrombus was identified in 19%. </span></span></span><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"> </span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#0e101a">The developed risk score demonstrated a clear association with thrombus formation (13% high-risk, 4% intermediate-risk and 1.5% low-risk group; p<0.01, χ2=17.02). ROC curve analysis revealed that the score had a robust predictive performance for early thrombus detection (AUC 0.82; p<0.01, 95% CI 0.68-0.95). </span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><span style="color:#0e101a">High-risk classification had a significant association with apical aneurism (p<0.01; χ2=11.88), previous acute myocardial infarction (p=0.02; x2 7.87), history of chronic pulmonary disease (p=0.01; χ2=9.07) and higher KK score (p<0.01; χ2=17.24). No differences between groups regarding 6 months (p=0.24) and 12 (p=0.30) months mortality and 12 months hospital re-admission (p=0.68).</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:#0e101a">Conclusion:</span></strong><span style="color:#0e101a"> These findings suggest that the proposed risk score effectively stratifies patients based on their risk of developing LVT following anterior STEMI and could be used in daily practice to determine which patients should be aggressively investigated. </span></span></span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site